Anti-TGF beta Receptor II antibody
Specifications
| Product Cat#: | AB-06-4321 |
| Product type: | Primary antibody |
| Antigen: | TGF beta Receptor II |
| Immunogen: | KLH conjugated synthetic peptide derived from human TGF beta R2 241-330/567 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400-1:2000); Immunohistochemistry-Paraffin (1:500-1:800) |
| Reactivity: | Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit, Sheep |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 10 mM Tris-HCl buffer (pH7.4), 1% BSA, 50% glycerol, 0.03% Proclin. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | TGF beta R2 |
| TGFBR2 | |
| TGF beta Receptor II | |
| AAT 3 | |
| AAT3 | |
| FAA 3 | |
| FAA3 | |
| HNPCC6 | |
| MFS 2 | |
| MFS2 | |
| RIIC | |
| TAAD 2 | |
| TAAD2 | |
| TbetaR II | |
| TGF beta receptor type 2 | |
| TGF beta receptor type II | |
| TGF beta type II receptor | |
| TGFB R2 | |
| TGFbeta RII | |
| TGFBR 2 | |
| TGFBR2 | |
| TGFR 2 | |
| TGFR2 | |
| Transforming growth factor beta receptor II | |
| Transforming growth factor beta receptor type II |
Target information
Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.
Provider
Erpantech Laboratory
